Clinical Trials Insight: 700035680

Trial Profile

Clinical Trials Insight: 700035680

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2009

At a glance

  • Drugs Adenosine triphosphate (Primary)
  • Indications Paroxysmal supraventricular tachycardia
  • Focus Registrational; Therapeutic Use
  • Sponsors Cordex Pharma
  • Most Recent Events

    • 02 Jun 2009 Status changed from planning to not yet recruiting, according to a Cordex Pharma media release.
    • 18 Feb 2009 Amended phase III protocol submitted to FDA, according to a media release from Cordex Pharma.
    • 20 Nov 2008 According to a Duska Therapeutics media release, this trial is expected to commence in quarter 1 of 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top